Interleukin-5 modulates interleukin-8 secretion in eosinophilic inflammation

SERUM and BALF (bro nch oalveolar lavage fluid) IL-8 leve ls and ser um le vels w e re in vestigated in To x o c a r a c a nis in fe cte d guin e a-pigs an d the ro le o f IL-5 as a m odulato r o f cytokin e se cr etion w as studie d. Serum leve ls in cr eased e arly in in fe cte d an im als, ex cee din g con tr ol leve ls 4 h afte r in fe ction , p eaked betw e en days 6 and 18, and con tin ue d to ex cee d con tro l leve ls afte r 48 days of in fe ction . Serum an d BALF IL-8 leve ls sh ow ed th e sam e p r ofile as blo od eo sin o ph ilia, in cr easin g 6 days p ost-in fe ction an d p e akin g betw e en days 18 an d 24. Tr eatm e nt o f in fe cte d an im als w ith an ti-IL-5 Ab s upp re sse d eo sin o p hilia w ith a p aralle l in cr ease in blood IL-8 levels , w h er eas no ch an ge w as fo un d in le vels. To sup po rt our in vivo o bs e rvation w e carrie d o ut ex p er im en ts in vitro usin g guin ea-pig LPSstim ulate d adh er en t p e rito ne al ce lls w h ic h r ele ase lar ge am o un ts of IL-8 in to th e sup er natants. Wh en rIL-5 w as adde d to LPS-stim ulated ce lls, 65% in hibition o f IL-8 re lease in to th e supe r natants w as observ ed. Pr e-in cubatio n o f cells w ith anti-IL-5 Ab p r eve nted th e in h ibitio n o f IL-8 r elease in to the supe r natants in duce d by rIL-5. Our r es ults de m on strate fo r th e firs t tim e th at TNF-a an d IL-8 are r eleased co ncom itan t w ith or afte r IL-5 in th e eos in o p hilic in flam m atio n in duce d by T. c a nis . Mor eo ver, in addition to sho w in g that IL-5 is fundam e ntal for the in duction o f bloo d eo sin o ph ilia, th e p re sen t r es ults suggest th at th is cytokin e m ay p lay a ne w biological r ole by actin g as m o dulato r o f IL-8 secr etion .

[1]  L. Faccioli,et al.  IL-5 drives eosinophils from bone marrow to blood and tissues in a guinea-pig model of visceral larva migrans syndrome , 1996, Mediators of inflammation.

[2]  B. Vargaftig,et al.  Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Iannuzzi,et al.  Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis. , 1995, American journal of respiratory and critical care medicine.

[4]  R. Strieter,et al.  TNF-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. , 1995, Journal of immunology.

[5]  H. Pircher,et al.  Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia , 1995, The Journal of experimental medicine.

[6]  B. Vargaftig,et al.  Role of interleukin‐5 in enhanced migration of eosinophils from airways of immunized guinea‐pigs , 1994, British journal of pharmacology.

[7]  I. Adcock,et al.  Tumor necrosis factor-induced interleukin-8 expression in cultured human airway epithelial cells. , 1994, The American journal of physiology.

[8]  A. Wardlaw,et al.  Interleukin‐8 is a chemo‐attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  L. M. Alves,et al.  Tumour necrosis factor production in vivo and in vitro in response to Paracoccidioides brasiliensis and the cell wall fractions thereof , 1993, Clinical and experimental immunology.

[10]  L. Faccioli,et al.  Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo. , 1993, Immunology.

[11]  R. Braun,et al.  Human peripheral blood eosinophils produce and release interleukin‐8 on stimulation with calcium ionophore , 1993, European journal of immunology.

[12]  A. Inglot,et al.  Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. , 1993, The American review of respiratory disease.

[13]  T. Takishima,et al.  Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggering. , 1992, American journal of respiratory cell and molecular biology.

[14]  H. Mikawa,et al.  Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B cells , 1992, The Journal of experimental medicine.

[15]  N. Sheron,et al.  IL‐8 as a circulating cytokine: induction by recombinant tumour necrosis factor‐alpha , 1992, Clinical and experimental immunology.

[16]  L. Olgiati,et al.  Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers. , 1992, Blood.

[17]  S. Mattoli,et al.  Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. , 1992, The Journal of allergy and clinical immunology.

[18]  S. Becker,et al.  Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. , 1991, Journal of immunology.

[19]  M. Cybulsky,et al.  Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. , 1991, Journal of immunology.

[20]  A J Wardlaw,et al.  Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. , 1991, The Journal of clinical investigation.

[21]  H. Büller,et al.  Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways , 1990 .

[22]  A. Limaye,et al.  Regulation of parasite-induced eosinophilia: selectively increased interleukin 5 production in helminth-infected patients , 1990, The Journal of experimental medicine.

[23]  E. A. Havell Evidence that tumor necrosis factor has an important role in antibacterial resistance. , 1989, Journal of immunology.

[24]  R. Coffman,et al.  Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. , 1989, Science.

[25]  V. Kindler,et al.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection , 1989, Cell.

[26]  I. Otterness,et al.  Monokine production by hypersensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages. Evidence for sequential production of IL-1 and tumor necrosis factor. , 1989, Journal of immunology.

[27]  T. Suda,et al.  Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors , 1988, The Journal of experimental medicine.

[28]  K. Matsushima,et al.  Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). , 1987, Journal of immunology.

[29]  D. Bowman,et al.  Tissue localization of excretory-secretory antigens of larval Toxocara canis in acute and chronic murine toxocariasis. , 1986, The American journal of tropical medicine and hygiene.

[30]  E. Goetzl,et al.  The human eosinophil: roles in host defense and tissue injury. , 1980, The American journal of pathology.

[31]  S. Kayes,et al.  Effect of inoculum size and length of infection on the distribution of Toxocara canis larvae in the mouse. , 1976, The American journal of tropical medicine and hygiene.

[32]  J. Westwick,et al.  Interleukin-8--a mediator of inflammatory lung disease? , 1991, Advances in experimental medicine and biology.

[33]  T. Standiford,et al.  Tumor necrosis factor-alpha, interleukin-8 and chemotactic cytokines. , 1990, Progress in clinical and biological research.

[34]  R. Tompkins,et al.  Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. , 1990, The Journal of infectious diseases.

[35]  T. Nutman,et al.  The eosinophil, eosinophilia, and eosinophil-related disorders. IV. Eosinophil related disorders (continued). , 1989, Allergy proceedings : the official journal of regional and state allergy societies.